The Regulation of m6A Modification in Glioblastoma: Functional Mechanisms and Therapeutic Approaches

Glioblastoma is the most prevalent primary brain tumour and invariably confers a poor prognosis. The immense intra-tumoral heterogeneity of glioblastoma and its ability to rapidly develop treatment resistance are key barriers to successful therapy. As such, there is an urgent need for the greater un...

Full description

Bibliographic Details
Main Authors: Simon Deacon, Lauryn Walker, Masar Radhi, Stuart Smith
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/15/13/3307
_version_ 1797592086804955136
author Simon Deacon
Lauryn Walker
Masar Radhi
Stuart Smith
author_facet Simon Deacon
Lauryn Walker
Masar Radhi
Stuart Smith
author_sort Simon Deacon
collection DOAJ
description Glioblastoma is the most prevalent primary brain tumour and invariably confers a poor prognosis. The immense intra-tumoral heterogeneity of glioblastoma and its ability to rapidly develop treatment resistance are key barriers to successful therapy. As such, there is an urgent need for the greater understanding of the tumour biology in order to guide the development of novel therapeutics in this field. N6-methyladenosine (m6A) is the most abundant of the RNA modifications in eukaryotes. Studies have demonstrated that the regulation of this RNA modification is altered in glioblastoma and may serve to regulate diverse mechanisms including glioma stem-cell self-renewal, tumorigenesis, invasion and treatment evasion. However, the precise mechanisms by which m6A modifications exert their functional effects are poorly understood. This review summarises the evidence for the disordered regulation of m6A in glioblastoma and discusses the downstream functional effects of m6A modification on RNA fate. The wide-ranging biological consequences of m6A modification raises the hope that novel cancer therapies can be targeted against this mechanism.
first_indexed 2024-03-11T01:46:26Z
format Article
id doaj.art-ba87a4735c61456db6d1746ff1e5fe76
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-11T01:46:26Z
publishDate 2023-06-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-ba87a4735c61456db6d1746ff1e5fe762023-11-18T16:15:05ZengMDPI AGCancers2072-66942023-06-011513330710.3390/cancers15133307The Regulation of m6A Modification in Glioblastoma: Functional Mechanisms and Therapeutic ApproachesSimon Deacon0Lauryn Walker1Masar Radhi2Stuart Smith3Children’s Brain Tumour Research Centre, University of Nottingham, Nottingham NG7 2RD, UKChildren’s Brain Tumour Research Centre, University of Nottingham, Nottingham NG7 2RD, UKChildren’s Brain Tumour Research Centre, University of Nottingham, Nottingham NG7 2RD, UKChildren’s Brain Tumour Research Centre, University of Nottingham, Nottingham NG7 2RD, UKGlioblastoma is the most prevalent primary brain tumour and invariably confers a poor prognosis. The immense intra-tumoral heterogeneity of glioblastoma and its ability to rapidly develop treatment resistance are key barriers to successful therapy. As such, there is an urgent need for the greater understanding of the tumour biology in order to guide the development of novel therapeutics in this field. N6-methyladenosine (m6A) is the most abundant of the RNA modifications in eukaryotes. Studies have demonstrated that the regulation of this RNA modification is altered in glioblastoma and may serve to regulate diverse mechanisms including glioma stem-cell self-renewal, tumorigenesis, invasion and treatment evasion. However, the precise mechanisms by which m6A modifications exert their functional effects are poorly understood. This review summarises the evidence for the disordered regulation of m6A in glioblastoma and discusses the downstream functional effects of m6A modification on RNA fate. The wide-ranging biological consequences of m6A modification raises the hope that novel cancer therapies can be targeted against this mechanism.https://www.mdpi.com/2072-6694/15/13/3307glioblastomaepitranscriptomicsRNA methylation
spellingShingle Simon Deacon
Lauryn Walker
Masar Radhi
Stuart Smith
The Regulation of m6A Modification in Glioblastoma: Functional Mechanisms and Therapeutic Approaches
Cancers
glioblastoma
epitranscriptomics
RNA methylation
title The Regulation of m6A Modification in Glioblastoma: Functional Mechanisms and Therapeutic Approaches
title_full The Regulation of m6A Modification in Glioblastoma: Functional Mechanisms and Therapeutic Approaches
title_fullStr The Regulation of m6A Modification in Glioblastoma: Functional Mechanisms and Therapeutic Approaches
title_full_unstemmed The Regulation of m6A Modification in Glioblastoma: Functional Mechanisms and Therapeutic Approaches
title_short The Regulation of m6A Modification in Glioblastoma: Functional Mechanisms and Therapeutic Approaches
title_sort regulation of m6a modification in glioblastoma functional mechanisms and therapeutic approaches
topic glioblastoma
epitranscriptomics
RNA methylation
url https://www.mdpi.com/2072-6694/15/13/3307
work_keys_str_mv AT simondeacon theregulationofm6amodificationinglioblastomafunctionalmechanismsandtherapeuticapproaches
AT laurynwalker theregulationofm6amodificationinglioblastomafunctionalmechanismsandtherapeuticapproaches
AT masarradhi theregulationofm6amodificationinglioblastomafunctionalmechanismsandtherapeuticapproaches
AT stuartsmith theregulationofm6amodificationinglioblastomafunctionalmechanismsandtherapeuticapproaches
AT simondeacon regulationofm6amodificationinglioblastomafunctionalmechanismsandtherapeuticapproaches
AT laurynwalker regulationofm6amodificationinglioblastomafunctionalmechanismsandtherapeuticapproaches
AT masarradhi regulationofm6amodificationinglioblastomafunctionalmechanismsandtherapeuticapproaches
AT stuartsmith regulationofm6amodificationinglioblastomafunctionalmechanismsandtherapeuticapproaches